Xywav Gets FDA Approval to Treat Rare Sleep Disorder
First drug to be approved by the agency for idiopathic hypersomnia
Largest U.S. Teachers’ Union Supports Mandatory COVID-19 Vaccination
Union says nearly 90 percent of its members report being fully vaccinated
NSAID Eye Drops May Suffice for Cataract Surgery Prophylaxis
Initiation of prophylactic treatment three days before surgery is not superior to initiation on day of surgery
AAP: Consider Palivizumab for Atypical Interseasonal RSV
AAP strongly supports consideration of palivizumab for patients who would be candidates per current eligibility recommendations
mRNA-1273 SARS-CoV-2 Vaccine Seems Safe for Adolescents
Interim analysis shows immune response in adolescents aged 12 to 17 years noninferior to that in young adults aged 18 to 25 years
Features of Vaccine-Induced Thrombotic Syndrome Studied
No individual risk factors identified for VITT, but increased mortality seen for those with cerebral venous sinus thrombosis, low platelets
DPP-4i Use May Protect in Alzheimer Dementia With Diabetes
Low amyloid burden and favorable cognitive outcomes seen with DPP-4i use in Alzheimer disease-related cognitive impairment with diabetes
Some Newer Antiseizure Meds May Not Increase Suicide Risk
Current evidence does not support increased suicidality for certain newer antiseizure medications; class warning may not be merited
Most Preprocedural Urinalyses Represent Low-Value Care
Between six and 28 percent of preprocedural urinalyses that were not indicated were followed by an antibiotic prescription
FDA to Approve COVID-19 Booster Shots for Vulnerable Americans
About 3 percent of Americans have weakened immune systems
